Search

Your search keyword '"Hyams, Catherine"' showing total 189 results

Search Constraints

Start Over You searched for: Author "Hyams, Catherine" Remove constraint Author: "Hyams, Catherine"
189 results on '"Hyams, Catherine"'

Search Results

2. Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort study

3. Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006-2022

5. Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

7. Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study

9. Serotype Distribution and Disease Severity in Adults Hospitalized with Streptococcus pneumoniae Infection, Bristol and Bath, UK, 2006-2022.

10. Syndromic case definitions for Lower Respiratory Tract Infection (LRTI) are less sensitive in older age: an analysis of symptoms among hospitalised adults

11. Association of ABO and Rhesus blood groups with severe outcomes from non‐SARS‐CoV‐2 respiratory infection: A prospective observational cohort study in Bristol, UK 2020–2022.

13. Impact of vaccination on the association of COVID-19 with arterial and venous thrombotic diseases: an OpenSAFELY cohort study using linked electronic health records

14. Use of illness severity scores to predict mortality in interstitial lung disease patients hospitalised with acute respiratory deterioration

15. Parapneumonic effusions related toStreptococcus pneumoniae: serotype and disease severity trends from 2006 to 2018 in Bristol, UK

16. Relative vaccine effectiveness of mRNA COVID-19 boosters in people aged at least 75 years during the spring-summer (monovalent vaccine) and autumnwinter (bivalent vaccine) booster campaigns: a prospective test negative case–control study, United Kingdom, 2022.

17. Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults.

18. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

19. Effectiveness of BNT162b2 COVID-19 vaccination in prevention of hospitalisations and severe disease in adults with SARS-CoV-2 Delta (B.1.617.2) and Omicron (B.1.1.529) variant between June 2021 and July 2022: a prospective test negative case–control study

20. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19

21. sj-pdf-2-jrs-10.1177_01410768231184162 - Supplemental material for Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults

22. sj-pdf-4-jrs-10.1177_01410768231184162 - Supplemental material for Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults

23. sj-pdf-1-jrs-10.1177_01410768231184162 - Supplemental material for Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adults

25. Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort study

26. Bayesian Prediction of Severe Outcomes in the LabMarCS: Laboratory Markers of COVID-19 Severity - Bristol Cohort

27. Author Reply to Peer Reviews of Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19

28. Severity of Omicron (B.1.1.529) and Delta (B.1.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study

29. Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom

30. Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology

31. Hyperactive immature state and differential CXCR2 expression of neutrophils in severe COVID-19

32. Parapneumonic effusions related toStreptococcus pneumoniae: serotype and disease severity trends from 2006 to 2018 in Bristol, UK

35. Impact of SARS-CoV-2 Infective Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) on Clinical Outcomes in a Prospective Cohort Study of Hospitalised Adults

36. Parapneumonic Effusions Related to Streptococcus Pneumoniae: Serotype and Disease Severity Trends

37. Incidence of Community Acquired Lower Respiratory Tract Disease in Bristol, UK During the COVID-19 Pandemic

38. Effectiveness of BNT162b2 COVID-19 Vaccination in Prevention of Hospitalisations and Severe Disease in Adults with Delta (B.1.617.2) and Omicron (B.1.1.529) Variant SARS-CoV-2 Infection: A Prospective Test Negative Case-Control Study

47. Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications

49. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

50. Assessing the Effectiveness of BNT162b2 and ChAdOx1nCoV-19 COVID-19 Vaccination in Prevention of Hospitalisations in Elderly and Frail Adults: A Single Centre Test Negative Case-Control Study

Catalog

Books, media, physical & digital resources